| Pharmacological characterization of the seven human NOX isoforms and their inhibitors | Redox Biology |  | | 2019 | 451 | 430 |
|
| Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis | Free radical biology & medicine | | | 2016 | 677 | 304 |
|
| Biodegradable and plasma-treated electrospun scaffolds coated with recombinant Olfactomedin-like 3 for accelerating wound healing and tissue regeneration | Wound repair and regeneration |  | | 2016 | 565 | 3 |
|
| Pharmacology and Clinical Drug Candidates in Redox Medicine | Antioxidants & redox signaling | | | 2015 | 530 | 722 |
|
| Reactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical Indications | Antioxidants & redox signaling | | | 2015 | 605 | 660 |
|
| Detection of reactive oxygen species derived from the family of NOX NADPH oxidases | Free radical biology & medicine | | | 2012 | 720 | 2 |
|
